Gene therapy with voretigene neparvovec-rzyl partially restores geniculostriate pathway function in LCA2 patients, improving visual processing. Initial LCA2 pathology shifts visual processing from the ...
Vision loss has long been treated as a one-way street, a devastating endpoint rather than a problem the brain might quietly work to solve. A wave of research is now overturning that assumption, ...
A recent study in Frontiers in Human Neuroscience shows a new approach called Perceptual Attention Therapy (PATH) restores attention, memory and reading skills more effectively than standard therapies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results